Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Max Planck reports cysteine-containing compounds as MMP inhibitors

Jan. 12, 1999

Shionogi patents water-soluble inhibitors of human sPLA2

Jan. 12, 1999

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

New COX-2 inhibitor series patented by Searle

Jan. 4, 1999

Gene transfer of plasmid DNA encoding TGF-beta for suppressing inflammation in arthritis

Dec. 30, 1998

SmithKline Beecham announces setback in RA trials

Dec. 30, 1998

Cytokine production inhibitors for inflammatory disorders in development at Ortho-McNeil

Dec. 30, 1998

Synvisc cleared for marketing in several Pacific Rim countries

Dec. 29, 1998

Phase II trial results for Immune Response's therapeutic RA vaccine published

Dec. 29, 1998

Combination of PGE1 + rolipram or pentoxifylline shows potential for RA

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...